Trenton, NJ - In a press conference this week, the New Jersey Senate Republican leadership released a 36 bill package to improve the state of innovation, the strengthen the workforce and grow the economy. The bills seek to usher in growth through policies pertaining to science and technology, STEM education, improving the state's existing economic development practices, regulation reductions as well as agriculture enhancements without adding additional costs to the budget.
|
Summit, NJ - The Celgene Corporation and San Diego-based Quanticel Pharmaceuticals, Inc., a privately held biotechnology company focused on cancer drug discovery, announce a definitive share purchase agreement under which Celgene Corporation will acquire Quanticel. Through the agreement, Celgene will have full access to Quanticel's proprietary platform for the single-cell genomic analysis of human cancer, as well as Quanticel's lead programs that target specific epigenetic modifiers to advance Celgene's pipeline of innovative cancer therapies.
|
Newark, NJ - The New Jersey Innovation Institute (NJII), an NJIT Corporation that applies the intellectual and technological resources of the state's science and technology university to challenges identified by industry partners, has assembled an interdisciplinary team of NJIT students to create innovative ways to reduce fare evasion on NJ Transit's Light Rail System.
|
Montvale, NJ - According to Beth Fitzgerald of NJBiz, "Memorial Sloan Kettering Cancer Center said it will develop a third New Jersey outpatient cancer center, a $140 million Montvale facility that it hopes to open in April 2017. Sloan Kettering operates six outpatient cancer centers outside New York City, including a Basking Ridge center that opened in 2006 and a Middletown facility set to open next year. About 80 percent of cancer care is now delivered in outpatient facilities, and Sloan Kettering is part of a major expansion of outpatient cancer care underway throughout the state." |
Teaneck, NJ - According to Hugh Morley of the Record, "Former medical company executive, Dr. Joseph V. Gulfo doesn't want to fight anymore. And that's good news for Fairleigh Dickinson University." After two years battling to get a melanoma detection device approved by the U.S. Food and Drug Administration, the former CEO of Mela Sciences is now the FDU's Rothman Institute of Innovation and Entrepreneurship. |
Pittsburgh, PA - ASSET STEM Education announced a third round of its STEM Scholarship Program. The program, launched in August 2014 in honor of ASSET's 20th anniversary, provides hands-on STEM classroom materials and educator professional development to underfunded schools and educational organizations to advance student success and workforce readiness.
|
Washington D.C. - The Council of State Governments (CSG) and Elsevier released recently "America's Knowledge Economy: A State-by-State Review," highlighting New Jersey's total output from corporate researchers was the highest among all states in the country (33,504 publications). Evaluating New Jersey from 2004 to 2013, 20.8% of its research came from the private sector, more than twice the rate of the entire country. |
|
|
When: April 29th
Where: Glassboro, NJ
|
When: April 30th
Where: New Brunswick, NJ
|
When: May 1-2
Where: Princeton, NJ
|
When: May 6th
Where: South Plainfield, NJ
|
Hosting an event?
Making groundbreaking research?
|
|
|